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ABSTRACT 
Objective: Cancer is a devastating public health problem all over the world. Herbal medicines have a vital role in the prevention and treatment of 
cancer. Papain is a proteolytic enzyme and a phyto therapeutic agent which highly appreciated in the medical field that prevents several chronic 
diseases such as cardiovascular disease, cancer and diabetes. The aim of the study describes about the cytotoxicity of papain against liver cancer cell 
line HepG2.  
Methods: In different concentrations of samples have been taken for cytotoxicity analysis using the MTT assay and calculate the percentage of cell 
viability.  
Results: The 50% inhibition concentration (IC50
Conclusion: 1000 µg/ml of papain has maximum (85%) cytotoxicity effect against liver cancer cell line hepG2. 
) of a sample was 125µg/ml and their cell viability percentage was 49.20. The 85% of cytotoxicity 
has been observed in 1000 µg/ml of papain against HepG2 cell line than other concentrations.  
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INTRODUCTION 
Nature is a source of medicinal agents for thousands of years. 
Various medicinal plants have been used for years in daily life to 
treat disease all over the world [1]. The commonest liver cancer is 
the hepatocellular carcinoma which is third most frequent cause of 
cancer death in India and fifth commonest cancer in the world [2]. 
Various parts of papaya include fruits, shoots, leaves, rinds, seeds, 
roots or latex have been traditionally used as ethno medicine for a 
number of disorders, including cancer [3].  
Papaya latex constitutes proteolytic enzyme papain, chymopapain, 
glutamine cyclotransferase, chymopapain A, B and C, peptidase A 
and B and lysozymes. Papain is an endolytic plant cysteine protease 
enzyme which is the major constituents of papaya [4]. It 
preferentially cleaves peptide bonds involving basic amino acids, 
particularly arginine, lysine and residues following phenylalanine 
[5]. Many cancer cells having a protective coating of fibrin. That is 
why the development of cancer may be undetected for many months 
and year. Due to this proteolytic activity of papain, it may break 
down the fibrin coat of cancer cell wall. Thus, ultimately it may help 
against the cancer. Hence, we aimed to study the efficacy of papain in 
cytotoxic activities against liver cancer cell line HepG2. To best of 
our knowledge, there are no literature available in this aspect and 
the present study may be the first kind of attempt in the global 
arena. 
MATERIALS AND METHODS 
Cell line (Hep G2) and culture 
A HepG2 cell line was obtained from National Centre for Cell 
Sciences, Pune (NCCS). The cells were maintained in Minimal 
Essential Medium supplemented with 10% FBS, penicillin (100 
U/ml), and streptomycin (100 μg/ml) in a humidified atmosphere of 
50 μg/ml CO2
MEM was purchased from Hi Media Laboratories Fetal Bovine 
Serum (FBS) was purchased from Cistron laboratories. Trypsin, 
methylthiazolyl diphenyl-tetrazolium bromide (MTT) and Dimethyl 
sulfoxide (DMSO) were purchased from Sisco research laboratory 
chemicals, Mumbai. All the other chemicals and reagents were 
obtained from Sigma Aldrich Mumbai. Commercial papain has been 
purchased from Sigma Aldrich to study the cytotoxic activity against 
hep G2 cell line.  
 at 37 °C. 
In vitro assay for anticancer activity (MTT Assay) [6] 
Cells (1 × 105/well) were plated in 24-well plates and incubated at 
370C with 5% CO2
The absorbance at 570 nm were measured with UV- Spectro 
photometer using DMSO as the blank. Measurements were 
performed and the concentration required for a 50% inhibition 
(IC
. After the cells reached the confluence, the 
various concentrations of the samples were added and incubated for 
24 hours. After incubation, the sample was removed from the well 
and washed with phosphate-buffered saline (pH 7.4) or MEM 
without serum. 100 µl/well (5mg/ml) of 0.5% 3-(4, 5-dimethyl-2-
thiazolyl)-2, 5-diphenyl-tetrazolium bromide (MTT) was added and 
incubated for 4 hours. After incubation, 1 ml of DMSO was added to 
all the wells.  
50
% cell viability = (A570 of treated cells / A570 of control cells) × 100 
) was determined graphically. The % cell viability was 
calculated using the following formula:   
RESULTS 
The Figure 1(a) indicates the control Hep G2 cell line. It indicates the 
cell viability of the HepG2 cells (i. e) 100%. Fig 1(b) has shown the 
feasible cell after 1000µg/ml of sample. It point out the cell viability 
of the Hep G2 cells when 1000µg/ml of papain added to it. The cell 
viability is 15.87% out of 100 % and in this concentration, lesser 
amount of cells are viable. Fig 1(c) has shown the viable cells after 
adjoining 125µg/ml of sample. It illustrates that the feasible Hep G2 
cells, when 125 µg/ml of sample noted up.  
The percentage of cells feasible are 49.20% which we can admit as 
consistent sum of cells demise. Fig1 (d) has shown the total cell 
survived adjoining 62.5 µg/ml of sample. It points up the conscious 
cells, when 62.5 µg/ml of sample transfer to it. The total cipher of 
cells exist are 61.90%, where another half of the cells are viable. It 
shows potential of that particular concentration of sample when 
added to it. Fig 1(e) has shown the existing cells subsequent to 
addition of 31.2 µg/ml of sample and it proves that 69.84%of cells 
are feasible (i. e.) nearly 3/4th
The effect of the samples on the proliferation of HepG2 were expressed 
as the percentage cell viability, using the following formula 
 cells are viable. It is not a vowing 
concentration of sample when we compare all the other.  
% cell viability = (A570 of treated cells / A570 of control cells) × 100 
International Journal of Pharmacy and Pharmaceutical Sciences 
ISSN- 0975-1491           Vol 6, Issue 9, 2014 
Innovare 
Academic Sciences 
Kumaresan et al. 
Int J Pharm Pharm Sci, Vol 6, Issue 9, 160-161 
161 
The HepG2 cell line with its anticancer activity of papain at various 
concentrations is listed below. The dilution rate at various ratio 
shows the feasibility of cells. These cells were absorbed under UV 
Spectrometer at 570 nm. In table.1 at the dilution rate of 1:4 the cell 
feasibility is consistent and its absorbance is 0.31 nm. 
 
 
Fig. 1(a): indicates the control Hep G2 cell line 
 
 
Fig. 1(b): has shown the feasible cell after 1000µg/ml of sample 
 
 








Fig. 1(e): has shown the existing cells subsequent to addition of 
31.2 µg/ml of sample 
Table: 1. 
S. No. Concentration (µg/ml) Cell viability (%) 
1 1000 15.87 
2 500 30.15 
3 250 42.85 
 4 125 49.20 
5 62.5 61.90 
6 31.2  69.84 
7 15.6 77.77 
8 7.8 84.12 
9 Cell control 100 
 
DISCUSSION 
Papain is a proteolytic enzyme which extracted & purified from papa
ya latex by advanced biochemical technology. The drugs containing 
papain have the functions of anti-cancer, anti-tumour, anti-
lymphatic leukemia, anti-lysogenic bacteriums and anti-parasite, 
anti-tubercle bacillus and etc. It can diminish inflammation lidan 
pain helps digestion, treatment women’s illnesses, glaucoma, osteo 
proliferation. Gun knife wound healing, Blood type identification, 
Mosquito bites and so on. No clinical or animal cancer studies were 
identified and only seven in vitro cell-culture-based studies were 
reported [7].  
The present study observed that papain has anticancer activity 
against liver cell carcinomas. This observation could gave a new 
dimension towards the curing of cancers using herbal medicine. This 
result may be the first kind of report because to best of our 
knowledge there are no data available to compare our results. But 
one earlier study [3] has revealed that many cancer cells having a 
protective coating of fibrin and papain breaks down that fibrin coat 
of cancer cell wall and protein into amino acid form. So ultimately it 
helps against the cancer. 
Really, the cytotoxicity of papain against liver cancer was a very 
good approach to bring out the platform for new drug discovery and 
delivery technologies. The present study results gave a remarkable 
finding and added a new feather to the papain family. 
In conclusion, papain has 85 % of cytotoxicity against HepG2 liver 
cancer cell line with the concentration of 1000µg/ml. Larger study 
needs to confirm our results. 
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